Literature DB >> 18790577

Estimating the number of U.S. incident cancers attributable to obesity and the impact on temporal trends in incidence rates for obesity-related cancers.

Anthony P Polednak1.   

Abstract

BACKGROUND: Reaching the American Cancer Society challenge goal for the nation to reduce cancer incidence by 25% by 2015 will be influenced in part by the epidemic of obesity. The purpose of this study was to estimate the impact of obesity on the number obesity-attributable incident cancers in the U.S. in 2007 and on trends on cancer incidence rates.
METHODS: Using estimated relative risks (RRs) for obesity vs. normal weight/height from published meta-analyses and/or large cohort studies, and the prevalence of obese adults from the latest national surveys, attributable risk percent (ARP) and numbers of obesity-attributed incident cancers in 2007 were estimated. Using the ARPs, the impact of obesity trends on trends in incidence rates for certain obesity-related cancers was estimated for the calendar years (1976-1980 through 2001-2004) for which cancer rates and obesity prevalence rates were available.
RESULTS: An estimated 33,966 new cancers (4% of all estimated cancers) in males and 50,535 (7% of all estimated cancers) in females diagnosed in 2007, or 6% of all cancers, may be potentially attributable to obesity. Without the impact of rising obesity rates, incidence rates might have declined (instead of remaining stable) from 1988-1994 to 2001-2004 for uterus, breast and certain other cancers.
CONCLUSIONS: Obesity may contribute to about 6% of U.S. incident cancers, apparently has affected recent trends in incidence rates for certain cancers, and is important because of increasing prevalence in the U.S. population.

Entities:  

Mesh:

Year:  2008        PMID: 18790577     DOI: 10.1016/j.cdp.2008.08.004

Source DB:  PubMed          Journal:  Cancer Detect Prev        ISSN: 0361-090X


  51 in total

1.  High knowledge about obesity and its health risks, with the exception of cancer, among Mexican individuals.

Authors:  Ruth Soriano; Sergio Ponce de León Rosales; Rusia García; Eduardo García-García; Juan Pablo Méndez
Journal:  J Cancer Educ       Date:  2012-06       Impact factor: 2.037

Review 2.  Heme oxygenase, a novel target for the treatment of hypertension and obesity?

Authors:  Peter A Hosick; David E Stec
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-11-09       Impact factor: 3.619

3.  Physical activity and sedentary behavior in relation to lung cancer incidence and mortality in older women: The Women's Health Initiative.

Authors:  Ange Wang; FeiFei Qin; Haley Hedlin; Manisha Desai; Rowan Chlebowski; Scarlett Gomez; Charles B Eaton; Karen C Johnson; Lihong Qi; Jean Wactawski-Wende; Catherine Womack; Heather A Wakelee; Marcia L Stefanick
Journal:  Int J Cancer       Date:  2016-11-15       Impact factor: 7.396

4.  Endometrial Cancer Insulin-Like Growth Factor 1 Receptor (IGF1R) Expression Increases with Body Mass Index and Is Associated with Pathologic Extent and Prognosis.

Authors:  Amy S Joehlin-Price; Julie A Stephens; Jianying Zhang; Floor J Backes; David E Cohn; Adrian A Suarez
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-12-18       Impact factor: 4.254

5.  Ovarian and uterine cancer incidence and mortality in American Indian and Alaska Native women, United States, 1999-2009.

Authors:  Simple D Singh; A Blythe Ryerson; Manxia Wu; Judith S Kaur
Journal:  Am J Public Health       Date:  2014-04-22       Impact factor: 9.308

6.  Gastric cardia cancer: how much is it from fat?

Authors:  Preetika Sinh; Prateek Sharma
Journal:  Dig Dis Sci       Date:  2012-10       Impact factor: 3.199

7.  Weight Fluctuation and Cancer Risk in Postmenopausal Women: The Women's Health Initiative.

Authors:  Laura M Welti; Daniel P Beavers; Bette J Caan; Haleh Sangi-Haghpeykar; Mara Z Vitolins; Kristen M Beavers
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-01-09       Impact factor: 4.254

8.  Parametrial fat tissue from high fat diet-treated SKH-1 mice stimulates transformation of mouse epidermal JB6 cells.

Authors:  Jamie J Bernard; You-Rong Lou; Qing-Yun Peng; Tao Li; Priyal R Vakil; Ning Ding; Jeffrey D Laskin; Zigang Dong; Allan H Conney; Yao-Ping Lu
Journal:  J Carcinog Mutagen       Date:  2014-07-31

9.  Trends in research on energy balance supported by the National Cancer Institute.

Authors:  Rachel Ballard-Barbash; Sameer M Siddiqi; David A Berrigan; Sharon A Ross; Linda C Nebeling; Emily C Dowling
Journal:  Am J Prev Med       Date:  2013-04       Impact factor: 5.043

Review 10.  Targeting obesity-related adipose tissue dysfunction to prevent cancer development and progression.

Authors:  Ayca Gucalp; Neil M Iyengar; Clifford A Hudis; Andrew J Dannenberg
Journal:  Semin Oncol       Date:  2015-09-08       Impact factor: 4.929

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.